Notably, the other antigens from the 6-molecule fingerprint, EpCAM, CD9, CD44, and CD59, showed a similar trend in expression change as that previously observed in preclinical models of docetaxel resistance and primary PCa patient samples (Supplementary Fig. S7B). Here, CD9 is linked to posterior cortical atrophy.